

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 8.60675213 |
| 2 | central nervous system myelination (GO:0022010) | 8.60675213 |
| 3 | fatty acid elongation (GO:0030497) | 5.73550654 |
| 4 | axon ensheathment (GO:0008366) | 4.82641419 |
| 5 | ensheathment of neurons (GO:0007272) | 4.82641419 |
| 6 | myelination (GO:0042552) | 4.73870977 |
| 7 | myelin maintenance (GO:0043217) | 4.42468028 |
| 8 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.05179448 |
| 9 | amyloid precursor protein metabolic process (GO:0042982) | 4.01216877 |
| 10 | virion attachment to host cell (GO:0019062) | 4.00120701 |
| 11 | adhesion of symbiont to host cell (GO:0044650) | 4.00120701 |
| 12 | creatine metabolic process (GO:0006600) | 3.81228113 |
| 13 | import into cell (GO:0098657) | 3.71060445 |
| 14 | amyloid precursor protein catabolic process (GO:0042987) | 3.69211614 |
| 15 | eye photoreceptor cell differentiation (GO:0001754) | 3.46620987 |
| 16 | photoreceptor cell differentiation (GO:0046530) | 3.46620987 |
| 17 | oligodendrocyte differentiation (GO:0048709) | 3.45694052 |
| 18 | positive regulation of cellular amine metabolic process (GO:0033240) | 3.40031757 |
| 19 | membrane raft organization (GO:0031579) | 3.37050915 |
| 20 | cholesterol biosynthetic process (GO:0006695) | 3.35767128 |
| 21 | negative regulation of protein localization to cell surface (GO:2000009) | 3.22805984 |
| 22 | response to lipoprotein particle (GO:0055094) | 3.21992711 |
| 23 | protein localization to endosome (GO:0036010) | 3.20784801 |
| 24 | adhesion of symbiont to host (GO:0044406) | 3.20601041 |
| 25 | GPI anchor biosynthetic process (GO:0006506) | 3.17099934 |
| 26 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.15546719 |
| 27 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.12425089 |
| 28 | barbed-end actin filament capping (GO:0051016) | 3.11763950 |
| 29 | low-density lipoprotein particle clearance (GO:0034383) | 3.10251172 |
| 30 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.08557817 |
| 31 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.07661316 |
| 32 | sphingoid metabolic process (GO:0046519) | 3.04250932 |
| 33 | Golgi to endosome transport (GO:0006895) | 3.02802325 |
| 34 | peripheral nervous system axon ensheathment (GO:0032292) | 3.00820492 |
| 35 | myelination in peripheral nervous system (GO:0022011) | 3.00820492 |
| 36 | sterol biosynthetic process (GO:0016126) | 2.99710475 |
| 37 | regulation of lipoprotein metabolic process (GO:0050746) | 2.99557335 |
| 38 | desmosome organization (GO:0002934) | 2.99357183 |
| 39 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.98799233 |
| 40 | glycosphingolipid catabolic process (GO:0046479) | 2.87855770 |
| 41 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.85196831 |
| 42 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.84889606 |
| 43 | response to methylmercury (GO:0051597) | 2.84637813 |
| 44 | presynaptic membrane assembly (GO:0097105) | 2.84244847 |
| 45 | GPI anchor metabolic process (GO:0006505) | 2.83135374 |
| 46 | pinocytosis (GO:0006907) | 2.82444222 |
| 47 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.81649475 |
| 48 | hypotonic response (GO:0006971) | 2.78718853 |
| 49 | glycolipid catabolic process (GO:0019377) | 2.77845641 |
| 50 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.77399269 |
| 51 | presynaptic membrane organization (GO:0097090) | 2.75028177 |
| 52 | isoprenoid biosynthetic process (GO:0008299) | 2.74426440 |
| 53 | diol metabolic process (GO:0034311) | 2.74223628 |
| 54 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.73599178 |
| 55 | membrane tubulation (GO:0097320) | 2.73038304 |
| 56 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.72452278 |
| 57 | sphingosine metabolic process (GO:0006670) | 2.71672072 |
| 58 | very long-chain fatty acid metabolic process (GO:0000038) | 2.70719676 |
| 59 | response to redox state (GO:0051775) | 2.69356548 |
| 60 | nucleotide transmembrane transport (GO:1901679) | 2.68502235 |
| 61 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.68439320 |
| 62 | mesodermal cell differentiation (GO:0048333) | 2.67601969 |
| 63 | enteric nervous system development (GO:0048484) | 2.66426112 |
| 64 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.66026192 |
| 65 | positive regulation of osteoblast proliferation (GO:0033690) | 2.65432889 |
| 66 | response to peptidoglycan (GO:0032494) | 2.63600013 |
| 67 | regulation of cholesterol homeostasis (GO:2000188) | 2.61528582 |
| 68 | magnesium ion transport (GO:0015693) | 2.61076000 |
| 69 | peptide catabolic process (GO:0043171) | 2.60779906 |
| 70 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.60706646 |
| 71 | sphingomyelin metabolic process (GO:0006684) | 2.59884618 |
| 72 | L-amino acid import (GO:0043092) | 2.59319682 |
| 73 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.58378693 |
| 74 | astrocyte development (GO:0014002) | 2.58124432 |
| 75 | regulation of cholesterol storage (GO:0010885) | 2.58029604 |
| 76 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.57406448 |
| 77 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.57301474 |
| 78 | cell-substrate junction assembly (GO:0007044) | 2.57144633 |
| 79 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.56869089 |
| 80 | regulation of osteoblast proliferation (GO:0033688) | 2.55815706 |
| 81 | detection of other organism (GO:0098543) | 2.55378517 |
| 82 | positive regulation of extracellular matrix organization (GO:1903055) | 2.55235054 |
| 83 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.52484930 |
| 84 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.51724829 |
| 85 | limb bud formation (GO:0060174) | 2.51717627 |
| 86 | positive regulation of receptor recycling (GO:0001921) | 2.50155013 |
| 87 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.49778604 |
| 88 | response to thyroid hormone (GO:0097066) | 2.48599742 |
| 89 | skin morphogenesis (GO:0043589) | 2.48271566 |
| 90 | glycosylceramide metabolic process (GO:0006677) | 2.48250052 |
| 91 | oligosaccharide catabolic process (GO:0009313) | 2.48043176 |
| 92 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.47578070 |
| 93 | regulation of collateral sprouting (GO:0048670) | 2.46803465 |
| 94 | regulation of macrophage chemotaxis (GO:0010758) | 2.46386913 |
| 95 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.45389325 |
| 96 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.45389325 |
| 97 | detection of bacterium (GO:0016045) | 2.44843368 |
| 98 | regulation of somitogenesis (GO:0014807) | 2.44646010 |
| 99 | hemidesmosome assembly (GO:0031581) | 2.44488342 |
| 100 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.43946746 |
| 101 | angiotensin maturation (GO:0002003) | 2.43317263 |
| 102 | negative regulation of cell killing (GO:0031342) | 2.42480309 |
| 103 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.42480309 |
| 104 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.40305438 |
| 105 | neutrophil activation involved in immune response (GO:0002283) | 2.39208379 |
| 106 | stress fiber assembly (GO:0043149) | 2.38309297 |
| 107 | regulation of vitamin metabolic process (GO:0030656) | 2.37716808 |
| 108 | negative regulation of chemokine production (GO:0032682) | 2.37493175 |
| 109 | positive regulation of pseudopodium assembly (GO:0031274) | 2.37037952 |
| 110 | axon development (GO:0061564) | 2.36816076 |
| 111 | phosphatidylserine metabolic process (GO:0006658) | 2.36392143 |
| 112 | positive regulation of glial cell differentiation (GO:0045687) | 2.36054953 |
| 113 | regulation of early endosome to late endosome transport (GO:2000641) | 2.34733067 |
| 114 | positive regulation of gliogenesis (GO:0014015) | 2.34334727 |
| 115 | cell adhesion mediated by integrin (GO:0033627) | 2.34182460 |
| 116 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.34079961 |
| 117 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.33236946 |
| 118 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.33137387 |
| 119 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.33137387 |
| 120 | modulation by symbiont of host immune response (GO:0052553) | 2.33137387 |
| 121 | positive regulation by symbiont of host defense response (GO:0052509) | 2.33137387 |
| 122 | modulation by symbiont of host defense response (GO:0052031) | 2.33137387 |
| 123 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.33137387 |
| 124 | apoptotic cell clearance (GO:0043277) | 2.33014392 |
| 125 | membrane protein ectodomain proteolysis (GO:0006509) | 2.32739460 |
| 126 | surfactant homeostasis (GO:0043129) | 2.32197979 |
| 127 | T-helper 1 type immune response (GO:0042088) | 2.32062468 |
| 128 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.31831694 |
| 129 | macrophage activation involved in immune response (GO:0002281) | 2.31679490 |
| 130 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.30945464 |
| 131 | detection of external biotic stimulus (GO:0098581) | 2.30731256 |
| 132 | mannose metabolic process (GO:0006013) | 2.29971104 |
| 133 | glycerophospholipid catabolic process (GO:0046475) | 2.29901249 |
| 134 | regulation of leukocyte degranulation (GO:0043300) | 2.29182019 |
| 135 | ceramide catabolic process (GO:0046514) | 2.28687924 |
| 136 | protein palmitoylation (GO:0018345) | 2.27686529 |
| 137 | negative regulation of interleukin-12 production (GO:0032695) | 2.26976058 |
| 138 | signal peptide processing (GO:0006465) | 2.26757700 |
| 139 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.26373370 |
| 140 | regulation of extracellular matrix disassembly (GO:0010715) | 2.26279863 |
| 141 | detection of molecule of bacterial origin (GO:0032490) | 2.25682607 |
| 142 | organ growth (GO:0035265) | 2.25469142 |
| 143 | regulation of pseudopodium assembly (GO:0031272) | 2.25027058 |
| 144 | mannosylation (GO:0097502) | 2.24056014 |
| 145 | regulation of pigment cell differentiation (GO:0050932) | 2.23245904 |
| 146 | membrane assembly (GO:0071709) | 2.22424265 |
| 147 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.22087185 |
| 148 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.21610069 |
| 149 | amino acid import (GO:0043090) | 2.21340324 |
| 150 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.21027204 |
| 151 | regulation of mast cell degranulation (GO:0043304) | 2.20331055 |
| 152 | acyl-CoA biosynthetic process (GO:0071616) | 2.18907132 |
| 153 | thioester biosynthetic process (GO:0035384) | 2.18907132 |
| 154 | omega-hydroxylase P450 pathway (GO:0097267) | 2.18793819 |
| 155 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.18442684 |
| 156 | positive regulation of blood coagulation (GO:0030194) | 2.18274303 |
| 157 | positive regulation of hemostasis (GO:1900048) | 2.18274303 |
| 158 | response to laminar fluid shear stress (GO:0034616) | 2.18201976 |
| 159 | nephron tubule formation (GO:0072079) | 2.16417399 |
| 160 | positive regulation of coagulation (GO:0050820) | 2.16004616 |
| 161 | cyclooxygenase pathway (GO:0019371) | 2.15588988 |
| 162 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.15184922 |
| 163 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.14640334 |
| 164 | C-terminal protein lipidation (GO:0006501) | 2.14101639 |
| 165 | glial cell development (GO:0021782) | 2.13791868 |
| 166 | Golgi transport vesicle coating (GO:0048200) | 2.13417364 |
| 167 | COPI coating of Golgi vesicle (GO:0048205) | 2.13417364 |
| 168 | ear development (GO:0043583) | 2.13032559 |
| 169 | neuron remodeling (GO:0016322) | 2.12244150 |
| 170 | positive regulation of leukocyte degranulation (GO:0043302) | 2.12060923 |
| 171 | regulation of cholesterol esterification (GO:0010872) | 2.11827825 |
| 172 | extracellular matrix assembly (GO:0085029) | 2.11756059 |
| 173 | regulation of superoxide anion generation (GO:0032928) | 2.11683355 |
| 174 | negative regulation of acute inflammatory response (GO:0002674) | 2.11080203 |
| 175 | endodermal cell differentiation (GO:0035987) | 2.10980498 |
| 176 | fibril organization (GO:0097435) | 2.09736294 |
| 177 | plasma lipoprotein particle clearance (GO:0034381) | 2.07607650 |
| 178 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.07284567 |
| 179 | granulocyte activation (GO:0036230) | 2.07238340 |
| 180 | protein-lipid complex assembly (GO:0065005) | 2.06587540 |
| 181 | regulation of water loss via skin (GO:0033561) | 2.06495376 |
| 182 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.06330557 |
| 183 | positive regulation of cholesterol efflux (GO:0010875) | 2.05073321 |
| 184 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.04967340 |
| 185 | regulation of necrotic cell death (GO:0010939) | 2.04890140 |
| 186 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.04871068 |
| 187 | decidualization (GO:0046697) | 2.03958476 |
| 188 | regulation of mononuclear cell migration (GO:0071675) | 2.03921937 |
| 189 | germinal center formation (GO:0002467) | 2.03392133 |
| 190 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.02350721 |
| 191 | hyaluronan catabolic process (GO:0030214) | 2.02093768 |
| 192 | regulation of extracellular matrix organization (GO:1903053) | 2.00539332 |
| 193 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.00351561 |
| 194 | negative regulation of fibrinolysis (GO:0051918) | 2.00238613 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.83137120 |
| 2 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.99465192 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.98450325 |
| 4 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.71792337 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.55811127 |
| 6 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.51503663 |
| 7 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.49388390 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.42379688 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.32603312 |
| 10 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.04757216 |
| 11 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.02925381 |
| 12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.00128670 |
| 13 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.98510847 |
| 14 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.93794213 |
| 15 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.89893863 |
| 16 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.85630731 |
| 17 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.85553830 |
| 18 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.81493215 |
| 19 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.80837289 |
| 20 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.78013843 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.76742795 |
| 22 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.74311677 |
| 23 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.74311677 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.71554112 |
| 25 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.69480044 |
| 26 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.64051872 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.63424249 |
| 28 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.61878825 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.58490947 |
| 30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55802336 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.54952323 |
| 32 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.54501698 |
| 33 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.53430416 |
| 34 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.52786236 |
| 35 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.52060076 |
| 36 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51477021 |
| 37 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.50431112 |
| 38 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.49443941 |
| 39 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48827891 |
| 40 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48270113 |
| 41 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.47101954 |
| 42 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.45273110 |
| 43 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44449470 |
| 44 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.44351580 |
| 45 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.43798764 |
| 46 | CJUN_26792858_Chip-Seq_BT549_Human | 1.43533592 |
| 47 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.41442618 |
| 48 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.41286307 |
| 49 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.40631198 |
| 50 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.38799636 |
| 51 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.38644549 |
| 52 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.38514736 |
| 53 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.38366236 |
| 54 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.37128395 |
| 55 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36854200 |
| 56 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.36730485 |
| 57 | * TCF7_22412390_ChIP-Seq_EML_Mouse | 1.35412531 |
| 58 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35355940 |
| 59 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34530557 |
| 60 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.33565933 |
| 61 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32762658 |
| 62 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.32624200 |
| 63 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.31084987 |
| 64 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.30823269 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.30677952 |
| 66 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.29975507 |
| 67 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.28919111 |
| 68 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.27966013 |
| 69 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.27062644 |
| 70 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.21569431 |
| 71 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.21542779 |
| 72 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.20492699 |
| 73 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18281436 |
| 74 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17535044 |
| 75 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17488852 |
| 76 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17430171 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.16605583 |
| 78 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16354568 |
| 79 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.12726720 |
| 80 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12264994 |
| 81 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.12166387 |
| 82 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12035356 |
| 83 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.11901230 |
| 84 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11121867 |
| 85 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.11008660 |
| 86 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.10957225 |
| 87 | MAF_26560356_Chip-Seq_TH1_Human | 1.10095831 |
| 88 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09494506 |
| 89 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.09476023 |
| 90 | ATF3_27146783_Chip-Seq_COLON_Human | 1.08314415 |
| 91 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08183495 |
| 92 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06488673 |
| 93 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.05755412 |
| 94 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05632716 |
| 95 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.05481656 |
| 96 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04102152 |
| 97 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.04043668 |
| 98 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03282180 |
| 99 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02189882 |
| 100 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02009498 |
| 101 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.01788573 |
| 102 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.01525280 |
| 103 | KDM2B_26808549_Chip-Seq_K562_Human | 1.01058697 |
| 104 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00981506 |
| 105 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.00010663 |
| 106 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99943073 |
| 107 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99597646 |
| 108 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.99117823 |
| 109 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98904375 |
| 110 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98600614 |
| 111 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.97553771 |
| 112 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.96027063 |
| 113 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.95017363 |
| 114 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94763759 |
| 115 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94533272 |
| 116 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.94171970 |
| 117 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.93423261 |
| 118 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.93423261 |
| 119 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93237518 |
| 120 | TP53_16413492_ChIP-PET_HCT116_Human | 0.92450768 |
| 121 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.90527602 |
| 122 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 0.90319118 |
| 123 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.90126416 |
| 124 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.89929930 |
| 125 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.89490878 |
| 126 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.89433194 |
| 127 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.89134064 |
| 128 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.88040210 |
| 129 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.87387890 |
| 130 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.86712078 |
| 131 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.86308985 |
| 132 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.85995357 |
| 133 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.85986117 |
| 134 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.85295280 |
| 135 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84998623 |
| 136 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.84771918 |
| 137 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.84303420 |
| 138 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.83524794 |
| 139 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.82869877 |
| 140 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.82480670 |
| 141 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.82444095 |
| 142 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.81654586 |
| 143 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.81624567 |
| 144 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.81485416 |
| 145 | GATA1_22025678_ChIP-Seq_K562_Human | 0.79455491 |
| 146 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.78703791 |
| 147 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.78549487 |
| 148 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.78236430 |
| 149 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.78106237 |
| 150 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.77977985 |
| 151 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.77977985 |
| 152 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.77815397 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 4.09386815 |
| 2 | MP0003950_abnormal_plasma_membrane | 4.04402968 |
| 3 | MP0003136_yellow_coat_color | 3.26749598 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.19049833 |
| 5 | MP0004381_abnormal_hair_follicle | 2.82807924 |
| 6 | MP0003303_peritoneal_inflammation | 2.55253858 |
| 7 | MP0003436_decreased_susceptibility_to | 2.54963062 |
| 8 | MP0003724_increased_susceptibility_to | 2.48539876 |
| 9 | MP0003690_abnormal_glial_cell | 2.42961220 |
| 10 | MP0005409_darkened_coat_color | 2.37309861 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.36270416 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 2.31562766 |
| 13 | MP0000566_synostosis | 2.31086842 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.27264125 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.23892734 |
| 16 | MP0005464_abnormal_platelet_physiology | 2.17911279 |
| 17 | MP0010234_abnormal_vibrissa_follicle | 2.17112572 |
| 18 | MP0009840_abnormal_foam_cell | 2.15188948 |
| 19 | MP0008260_abnormal_autophagy | 2.12647911 |
| 20 | MP0004272_abnormal_basement_membrane | 2.03440438 |
| 21 | MP0005171_absent_coat_pigmentation | 2.01583871 |
| 22 | MP0005360_urolithiasis | 1.99596113 |
| 23 | MP0005275_abnormal_skin_tensile | 1.92582135 |
| 24 | MP0000383_abnormal_hair_follicle | 1.92278177 |
| 25 | MP0004947_skin_inflammation | 1.91107009 |
| 26 | MP0009379_abnormal_foot_pigmentation | 1.90968997 |
| 27 | MP0005365_abnormal_bile_salt | 1.79225380 |
| 28 | MP0003172_abnormal_lysosome_physiology | 1.75419561 |
| 29 | MP0000465_gastrointestinal_hemorrhage | 1.74729226 |
| 30 | MP0010678_abnormal_skin_adnexa | 1.73078963 |
| 31 | MP0002933_joint_inflammation | 1.63751915 |
| 32 | MP0005451_abnormal_body_composition | 1.63236564 |
| 33 | MP0000858_altered_metastatic_potential | 1.56958079 |
| 34 | MP0000579_abnormal_nail_morphology | 1.55107181 |
| 35 | MP0001958_emphysema | 1.52010477 |
| 36 | MP0003453_abnormal_keratinocyte_physiol | 1.47191481 |
| 37 | MP0010155_abnormal_intestine_physiology | 1.46317660 |
| 38 | MP0001835_abnormal_antigen_presentation | 1.44189469 |
| 39 | MP0009384_cardiac_valve_regurgitation | 1.43651646 |
| 40 | MP0002295_abnormal_pulmonary_circulatio | 1.43157314 |
| 41 | MP0002796_impaired_skin_barrier | 1.42418550 |
| 42 | MP0001851_eye_inflammation | 1.41998621 |
| 43 | MP0004185_abnormal_adipocyte_glucose | 1.39993180 |
| 44 | MP0004510_myositis | 1.39780850 |
| 45 | MP0000749_muscle_degeneration | 1.38346512 |
| 46 | MP0000762_abnormal_tongue_morphology | 1.37182231 |
| 47 | MP0003634_abnormal_glial_cell | 1.34476483 |
| 48 | MP0000462_abnormal_digestive_system | 1.33620319 |
| 49 | MP0004134_abnormal_chest_morphology | 1.33293597 |
| 50 | MP0001849_ear_inflammation | 1.32908618 |
| 51 | MP0000647_abnormal_sebaceous_gland | 1.32587597 |
| 52 | MP0002877_abnormal_melanocyte_morpholog | 1.29564189 |
| 53 | MP0001346_abnormal_lacrimal_gland | 1.23949069 |
| 54 | MP0006054_spinal_hemorrhage | 1.21452621 |
| 55 | MP0000343_altered_response_to | 1.21237730 |
| 56 | MP0008004_abnormal_stomach_pH | 1.20892495 |
| 57 | MP0001533_abnormal_skeleton_physiology | 1.20229957 |
| 58 | MP0005166_decreased_susceptibility_to | 1.19683997 |
| 59 | MP0003806_abnormal_nucleotide_metabolis | 1.19635889 |
| 60 | MP0000372_irregular_coat_pigmentation | 1.15235092 |
| 61 | MP0002452_abnormal_antigen_presenting | 1.14229999 |
| 62 | MP0003329_amyloid_beta_deposits | 1.13553400 |
| 63 | MP0001845_abnormal_inflammatory_respons | 1.13268927 |
| 64 | MP0003183_abnormal_peptide_metabolism | 1.13173473 |
| 65 | MP0004742_abnormal_vestibular_system | 1.13032100 |
| 66 | MP0005503_abnormal_tendon_morphology | 1.12205743 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.12046496 |
| 68 | MP0002419_abnormal_innate_immunity | 1.11240145 |
| 69 | MP0006082_CNS_inflammation | 1.10900256 |
| 70 | MP0003279_aneurysm | 1.10779306 |
| 71 | MP0005408_hypopigmentation | 1.10457370 |
| 72 | MP0005165_increased_susceptibility_to | 1.09445144 |
| 73 | MP0009764_decreased_sensitivity_to | 1.09079254 |
| 74 | MP0003448_altered_tumor_morphology | 1.08538283 |
| 75 | MP0008469_abnormal_protein_level | 1.07810055 |
| 76 | MP0000613_abnormal_salivary_gland | 1.07385053 |
| 77 | MP0002723_abnormal_immune_serum | 1.07326248 |
| 78 | MP0009333_abnormal_splenocyte_physiolog | 1.07009346 |
| 79 | MP0002998_abnormal_bone_remodeling | 1.06726697 |
| 80 | MP0009785_altered_susceptibility_to | 1.06636256 |
| 81 | MP0004264_abnormal_extraembryonic_tissu | 1.05896274 |
| 82 | MP0005257_abnormal_intraocular_pressure | 1.04331822 |
| 83 | MP0002060_abnormal_skin_morphology | 1.04132523 |
| 84 | MP0002148_abnormal_hypersensitivity_rea | 1.02928605 |
| 85 | MP0005085_abnormal_gallbladder_physiolo | 1.01391447 |
| 86 | MP0000249_abnormal_blood_vessel | 1.01123268 |
| 87 | MP0005164_abnormal_response_to | 1.00782309 |
| 88 | MP0001666_abnormal_nutrient_absorption | 1.00336596 |
| 89 | MP0001661_extended_life_span | 0.99932323 |
| 90 | MP0001545_abnormal_hematopoietic_system | 0.99693351 |
| 91 | MP0005397_hematopoietic_system_phenotyp | 0.99693351 |
| 92 | MP0001800_abnormal_humoral_immune | 0.97997420 |
| 93 | MP0001542_abnormal_bone_strength | 0.97354989 |
| 94 | MP0002098_abnormal_vibrissa_morphology | 0.95765944 |
| 95 | MP0000467_abnormal_esophagus_morphology | 0.95737309 |
| 96 | MP0001819_abnormal_immune_cell | 0.94826601 |
| 97 | MP0002420_abnormal_adaptive_immunity | 0.94778464 |
| 98 | MP0004885_abnormal_endolymph | 0.94636654 |
| 99 | MP0010329_abnormal_lipoprotein_level | 0.94554255 |
| 100 | MP0010352_gastrointestinal_tract_polyps | 0.94388691 |
| 101 | MP0004883_abnormal_blood_vessel | 0.93959034 |
| 102 | MP0009250_abnormal_appendicular_skeleto | 0.93596522 |
| 103 | MP0005501_abnormal_skin_physiology | 0.92705559 |
| 104 | MP0005666_abnormal_adipose_tissue | 0.91221346 |
| 105 | MP0004147_increased_porphyrin_level | 0.89480144 |
| 106 | MP0002405_respiratory_system_inflammati | 0.88769978 |
| 107 | MP0005025_abnormal_response_to | 0.87547137 |
| 108 | MP0005623_abnormal_meninges_morphology | 0.87364123 |
| 109 | MP0003075_altered_response_to | 0.87072044 |
| 110 | MP0000377_abnormal_hair_follicle | 0.86593922 |
| 111 | MP0003045_fibrosis | 0.86567875 |
| 112 | MP0004142_abnormal_muscle_tone | 0.86199836 |
| 113 | MP0005167_abnormal_blood-brain_barrier | 0.85873923 |
| 114 | MP0005390_skeleton_phenotype | 0.84669731 |
| 115 | MP0005375_adipose_tissue_phenotype | 0.84151124 |
| 116 | MP0003011_delayed_dark_adaptation | 0.83582593 |
| 117 | MP0005671_abnormal_response_to | 0.83465385 |
| 118 | MP0005381_digestive/alimentary_phenotyp | 0.83281202 |
| 119 | MP0002971_abnormal_brown_adipose | 0.82931065 |
| 120 | MP0004019_abnormal_vitamin_homeostasis | 0.82466713 |
| 121 | MP0005670_abnormal_white_adipose | 0.82234468 |
| 122 | MP0003656_abnormal_erythrocyte_physiolo | 0.82154062 |
| 123 | MP0001299_abnormal_eye_distance/ | 0.80928355 |
| 124 | MP0002009_preneoplasia | 0.80268311 |
| 125 | MP0005083_abnormal_biliary_tract | 0.79951386 |
| 126 | MP0002118_abnormal_lipid_homeostasis | 0.78617007 |
| 127 | MP0002254_reproductive_system_inflammat | 0.78616370 |
| 128 | MP0000747_muscle_weakness | 0.78448628 |
| 129 | MP0009643_abnormal_urine_homeostasis | 0.78258613 |
| 130 | MP0003091_abnormal_cell_migration | 0.78120816 |
| 131 | MP0001853_heart_inflammation | 0.78106495 |
| 132 | MP0005508_abnormal_skeleton_morphology | 0.77457152 |
| 133 | MP0001905_abnormal_dopamine_level | 0.77413574 |
| 134 | MP0005388_respiratory_system_phenotype | 0.76490087 |
| 135 | MP0002133_abnormal_respiratory_system | 0.76490087 |
| 136 | MP0000604_amyloidosis | 0.76268537 |
| 137 | MP0000733_abnormal_muscle_development | 0.76227121 |
| 138 | MP0005595_abnormal_vascular_smooth | 0.75806917 |
| 139 | MP0005023_abnormal_wound_healing | 0.75492029 |
| 140 | MP0003186_abnormal_redox_activity | 0.75393013 |
| 141 | MP0000685_abnormal_immune_system | 0.74075247 |
| 142 | MP0000751_myopathy | 0.71198727 |
| 143 | MP0003632_abnormal_nervous_system | 0.71060141 |
| 144 | MP0003566_abnormal_cell_adhesion | 0.70774496 |
| 145 | MP0001216_abnormal_epidermal_layer | 0.69286205 |
| 146 | MP0010368_abnormal_lymphatic_system | 0.69258474 |
| 147 | MP0010771_integument_phenotype | 0.69121295 |
| 148 | MP0001790_abnormal_immune_system | 0.69066094 |
| 149 | MP0005387_immune_system_phenotype | 0.69066094 |
| 150 | MP0003828_pulmonary_edema | 0.69023918 |
| 151 | MP0005000_abnormal_immune_tolerance | 0.68871475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Parakeratosis (HP:0001036) | 4.51940056 |
| 2 | Neurofibrillary tangles (HP:0002185) | 4.45867916 |
| 3 | Systemic lupus erythematosus (HP:0002725) | 3.63152226 |
| 4 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.55154061 |
| 5 | Eczematoid dermatitis (HP:0000976) | 3.40022334 |
| 6 | Peripheral hypomyelination (HP:0007182) | 3.37400876 |
| 7 | Muscle fiber splitting (HP:0003555) | 3.21600033 |
| 8 | Nonprogressive disorder (HP:0003680) | 3.15245397 |
| 9 | Premature rupture of membranes (HP:0001788) | 3.12153556 |
| 10 | Sensory axonal neuropathy (HP:0003390) | 3.06106298 |
| 11 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.02296731 |
| 12 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.02296731 |
| 13 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.99205041 |
| 14 | Onion bulb formation (HP:0003383) | 2.93464767 |
| 15 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.92409162 |
| 16 | Purpura (HP:0000979) | 2.91122523 |
| 17 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.86534917 |
| 18 | Axonal loss (HP:0003447) | 2.86395824 |
| 19 | Vacuolated lymphocytes (HP:0001922) | 2.85338182 |
| 20 | Premature skin wrinkling (HP:0100678) | 2.78981611 |
| 21 | Myocardial infarction (HP:0001658) | 2.73241447 |
| 22 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.70871630 |
| 23 | Vertebral compression fractures (HP:0002953) | 2.66343348 |
| 24 | Slow saccadic eye movements (HP:0000514) | 2.52882113 |
| 25 | Xanthomatosis (HP:0000991) | 2.52615358 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.52286321 |
| 27 | Protrusio acetabuli (HP:0003179) | 2.51936516 |
| 28 | Mucopolysacchariduria (HP:0008155) | 2.51529706 |
| 29 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.51529706 |
| 30 | Recurrent abscess formation (HP:0002722) | 2.51496054 |
| 31 | Cerebral inclusion bodies (HP:0100314) | 2.51039928 |
| 32 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.49604502 |
| 33 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.49604502 |
| 34 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.49604502 |
| 35 | Complement deficiency (HP:0004431) | 2.48020818 |
| 36 | Abnormality of complement system (HP:0005339) | 2.47309613 |
| 37 | Petechiae (HP:0000967) | 2.46630939 |
| 38 | Milia (HP:0001056) | 2.46555882 |
| 39 | Prolonged bleeding time (HP:0003010) | 2.45659837 |
| 40 | Deep venous thrombosis (HP:0002625) | 2.45362262 |
| 41 | Amyloidosis (HP:0011034) | 2.45335623 |
| 42 | Gingival bleeding (HP:0000225) | 2.44954587 |
| 43 | Recurrent bacterial skin infections (HP:0005406) | 2.42240438 |
| 44 | Hypoplasia of the iris (HP:0007676) | 2.41771337 |
| 45 | Stridor (HP:0010307) | 2.40442778 |
| 46 | Atrophic scars (HP:0001075) | 2.39648865 |
| 47 | Malnutrition (HP:0004395) | 2.36867468 |
| 48 | Glomerulonephritis (HP:0000099) | 2.36548371 |
| 49 | Patchy hypopigmentation of hair (HP:0011365) | 2.35041384 |
| 50 | Epistaxis (HP:0000421) | 2.33395669 |
| 51 | Polycythemia (HP:0001901) | 2.30973355 |
| 52 | Menorrhagia (HP:0000132) | 2.29167603 |
| 53 | Distal lower limb muscle weakness (HP:0009053) | 2.28905065 |
| 54 | Hepatosplenomegaly (HP:0001433) | 2.27119660 |
| 55 | Gingivitis (HP:0000230) | 2.24838923 |
| 56 | Hemorrhage of the eye (HP:0011885) | 2.24552419 |
| 57 | White forelock (HP:0002211) | 2.23809249 |
| 58 | Alacrima (HP:0000522) | 2.22698331 |
| 59 | Aplasia involving bones of the extremities (HP:0009825) | 2.21025799 |
| 60 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.21025799 |
| 61 | Aplasia of the phalanges of the hand (HP:0009802) | 2.21025799 |
| 62 | Plantar hyperkeratosis (HP:0007556) | 2.20239036 |
| 63 | Humeroradial synostosis (HP:0003041) | 2.19910979 |
| 64 | Synostosis involving the elbow (HP:0003938) | 2.19910979 |
| 65 | Spastic paraparesis (HP:0002313) | 2.18813350 |
| 66 | Spontaneous hematomas (HP:0007420) | 2.18411489 |
| 67 | Prolonged neonatal jaundice (HP:0006579) | 2.17847676 |
| 68 | Reduced antithrombin III activity (HP:0001976) | 2.17550686 |
| 69 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.17442989 |
| 70 | Ileus (HP:0002595) | 2.17105776 |
| 71 | Retinal dysplasia (HP:0007973) | 2.16927560 |
| 72 | Metabolic alkalosis (HP:0200114) | 2.15509823 |
| 73 | Alopecia of scalp (HP:0002293) | 2.13937770 |
| 74 | Myositis (HP:0100614) | 2.12738752 |
| 75 | Gowers sign (HP:0003391) | 2.12579725 |
| 76 | Orchitis (HP:0100796) | 2.12124979 |
| 77 | Increased connective tissue (HP:0009025) | 2.11128503 |
| 78 | Hyporeflexia of lower limbs (HP:0002600) | 2.09628678 |
| 79 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.09292320 |
| 80 | Abnormality of the 2nd finger (HP:0004100) | 2.08672339 |
| 81 | Abnormality of macrophages (HP:0004311) | 2.08598003 |
| 82 | Split foot (HP:0001839) | 2.07944857 |
| 83 | Abnormality of nail color (HP:0100643) | 2.07861180 |
| 84 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.06698102 |
| 85 | Increased serum ferritin (HP:0003281) | 2.06219101 |
| 86 | Distal lower limb amyotrophy (HP:0008944) | 2.05671257 |
| 87 | Pterygium (HP:0001059) | 2.05406602 |
| 88 | Cervical subluxation (HP:0003308) | 2.04943998 |
| 89 | Abnormal platelet volume (HP:0011876) | 2.04025934 |
| 90 | Abnormal blistering of the skin (HP:0008066) | 2.02635941 |
| 91 | Asymmetric septal hypertrophy (HP:0001670) | 2.02110602 |
| 92 | Barrel-shaped chest (HP:0001552) | 2.01164484 |
| 93 | Abnormal hemoglobin (HP:0011902) | 2.01057349 |
| 94 | Type I transferrin isoform profile (HP:0003642) | 1.99071359 |
| 95 | Increased mean platelet volume (HP:0011877) | 1.98816872 |
| 96 | Hypertriglyceridemia (HP:0002155) | 1.98453765 |
| 97 | Broad metatarsal (HP:0001783) | 1.98051422 |
| 98 | Fragile skin (HP:0001030) | 1.97815076 |
| 99 | Pulmonary artery stenosis (HP:0004415) | 1.97439350 |
| 100 | Dysostosis multiplex (HP:0000943) | 1.97294574 |
| 101 | Epiphyseal dysplasia (HP:0002656) | 1.96688294 |
| 102 | Anhidrosis (HP:0000970) | 1.94555124 |
| 103 | Pustule (HP:0200039) | 1.94312447 |
| 104 | Renal Fanconi syndrome (HP:0001994) | 1.94149541 |
| 105 | Increased IgE level (HP:0003212) | 1.94067497 |
| 106 | Abnormal auditory evoked potentials (HP:0006958) | 1.92360377 |
| 107 | Progressive neurologic deterioration (HP:0002344) | 1.91147695 |
| 108 | Thin bony cortex (HP:0002753) | 1.89476630 |
| 109 | Flat acetabular roof (HP:0003180) | 1.88842342 |
| 110 | Conical tooth (HP:0000698) | 1.88188654 |
| 111 | Cerebral aneurysm (HP:0004944) | 1.87000013 |
| 112 | Peritonitis (HP:0002586) | 1.85310050 |
| 113 | Abnormality of the axillary hair (HP:0100134) | 1.84213788 |
| 114 | Abnormality of secondary sexual hair (HP:0009888) | 1.84213788 |
| 115 | Vascular calcification (HP:0004934) | 1.83988889 |
| 116 | Nephritis (HP:0000123) | 1.82603007 |
| 117 | Onycholysis (HP:0001806) | 1.82522116 |
| 118 | Aortic aneurysm (HP:0004942) | 1.82252442 |
| 119 | Right ventricular cardiomyopathy (HP:0011663) | 1.81466574 |
| 120 | Amelogenesis imperfecta (HP:0000705) | 1.81445950 |
| 121 | Infantile muscular hypotonia (HP:0008947) | 1.81378893 |
| 122 | Abdominal distention (HP:0003270) | 1.81150496 |
| 123 | Abnormal platelet function (HP:0011869) | 1.80822615 |
| 124 | Impaired platelet aggregation (HP:0003540) | 1.80822615 |
| 125 | Osteolytic defects of the hand bones (HP:0009699) | 1.79723390 |
| 126 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.79723390 |
| 127 | Cardiovascular calcification (HP:0011915) | 1.79472146 |
| 128 | Abnormality of iron homeostasis (HP:0011031) | 1.79405669 |
| 129 | Vascular tortuosity (HP:0004948) | 1.79282628 |
| 130 | Mitral stenosis (HP:0001718) | 1.78722183 |
| 131 | Abnormality of the Achilles tendon (HP:0005109) | 1.78504069 |
| 132 | Cerebral hypomyelination (HP:0006808) | 1.78177879 |
| 133 | Abnormality of the common coagulation pathway (HP:0010990) | 1.77480402 |
| 134 | Joint hemorrhage (HP:0005261) | 1.76906699 |
| 135 | Aortic dissection (HP:0002647) | 1.76123074 |
| 136 | Corneal erosion (HP:0200020) | 1.76102014 |
| 137 | Bone pain (HP:0002653) | 1.75680081 |
| 138 | Arterial tortuosity (HP:0005116) | 1.75275461 |
| 139 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.75216940 |
| 140 | Increased cerebral lipofuscin (HP:0011813) | 1.74420970 |
| 141 | Nasolacrimal duct obstruction (HP:0000579) | 1.73730821 |
| 142 | Polygenic inheritance (HP:0010982) | 1.72236657 |
| 143 | Hypoplastic ischia (HP:0003175) | 1.72035741 |
| 144 | Abnormality of glycolipid metabolism (HP:0010969) | 1.71904417 |
| 145 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.71904417 |
| 146 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.71904417 |
| 147 | Autoamputation (HP:0001218) | 1.71841839 |
| 148 | Interstitial pulmonary disease (HP:0006530) | 1.71573184 |
| 149 | Partial duplication of thumb phalanx (HP:0009944) | 1.71495964 |
| 150 | Clumsiness (HP:0002312) | 1.71212064 |
| 151 | Ectropion (HP:0000656) | 1.71158548 |
| 152 | Respiratory distress (HP:0002098) | 1.71137938 |
| 153 | Nail dystrophy (HP:0008404) | 1.70672855 |
| 154 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.70403756 |
| 155 | Weak cry (HP:0001612) | 1.69897833 |
| 156 | Palmoplantar hyperkeratosis (HP:0000972) | 1.69804317 |
| 157 | Paraparesis (HP:0002385) | 1.69753288 |
| 158 | Cellulitis (HP:0100658) | 1.69732994 |
| 159 | Nemaline bodies (HP:0003798) | 1.69700932 |
| 160 | Thick nail (HP:0001805) | 1.68933992 |
| 161 | Urticaria (HP:0001025) | 1.68361942 |
| 162 | Loss of speech (HP:0002371) | 1.68095207 |
| 163 | Dilatation of the ascending aorta (HP:0005111) | 1.66924117 |
| 164 | Increased variability in muscle fiber diameter (HP:0003557) | 1.66921204 |
| 165 | Achilles tendon contracture (HP:0001771) | 1.66705829 |
| 166 | Muscle fiber inclusion bodies (HP:0100299) | 1.65765572 |
| 167 | Hypoplastic pelvis (HP:0008839) | 1.65539793 |
| 168 | Short hallux (HP:0010109) | 1.65198459 |
| 169 | Fragile nails (HP:0001808) | 1.64045932 |
| 170 | Episodic fever (HP:0001954) | 1.63695990 |
| 171 | Decreased lacrimation (HP:0000633) | 1.63451772 |
| 172 | Abnormal protein glycosylation (HP:0012346) | 1.63341238 |
| 173 | Abnormal glycosylation (HP:0012345) | 1.63341238 |
| 174 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.63341238 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 4.32978337 |
| 2 | EPHB1 | 3.97531699 |
| 3 | TNIK | 3.00092715 |
| 4 | MUSK | 2.98148897 |
| 5 | MAPKAPK5 | 2.69465549 |
| 6 | RIPK1 | 2.69289945 |
| 7 | MST4 | 2.65382893 |
| 8 | OXSR1 | 2.63575546 |
| 9 | MET | 2.32819197 |
| 10 | MAP3K3 | 2.26474880 |
| 11 | PBK | 2.22036449 |
| 12 | NLK | 2.20341814 |
| 13 | PRKD2 | 2.00955643 |
| 14 | MAP2K3 | 1.98138511 |
| 15 | RIPK4 | 1.97195975 |
| 16 | TRIB3 | 1.94488540 |
| 17 | PKN1 | 1.81824365 |
| 18 | ZAP70 | 1.77311213 |
| 19 | TYK2 | 1.76315931 |
| 20 | SIK1 | 1.69262033 |
| 21 | LMTK2 | 1.61052203 |
| 22 | CLK1 | 1.60614835 |
| 23 | TAOK2 | 1.54579411 |
| 24 | TRPM7 | 1.54493393 |
| 25 | CDK19 | 1.52519311 |
| 26 | CASK | 1.49741089 |
| 27 | FGFR4 | 1.49501218 |
| 28 | MAPK15 | 1.46262499 |
| 29 | EIF2AK3 | 1.42986328 |
| 30 | PDGFRA | 1.41982847 |
| 31 | MAP3K1 | 1.41960897 |
| 32 | IRAK3 | 1.39509573 |
| 33 | MAP3K11 | 1.38482744 |
| 34 | TIE1 | 1.38050560 |
| 35 | WNK4 | 1.34987222 |
| 36 | NME2 | 1.31054210 |
| 37 | MAP3K13 | 1.25797633 |
| 38 | TESK1 | 1.25382447 |
| 39 | CDC42BPA | 1.24762707 |
| 40 | JAK3 | 1.24408704 |
| 41 | ARAF | 1.22850447 |
| 42 | TESK2 | 1.22134131 |
| 43 | FGR | 1.21676012 |
| 44 | MAP3K2 | 1.21075668 |
| 45 | TGFBR2 | 1.19863807 |
| 46 | MAP4K1 | 1.19184102 |
| 47 | EPHA2 | 1.18558825 |
| 48 | CSNK1G1 | 1.15962548 |
| 49 | TAOK1 | 1.15709984 |
| 50 | ICK | 1.15500614 |
| 51 | PAK4 | 1.15259407 |
| 52 | KSR2 | 1.13717621 |
| 53 | IRAK1 | 1.13581280 |
| 54 | MAP2K2 | 1.11801594 |
| 55 | CAMK2D | 1.11582456 |
| 56 | MST1R | 1.11068832 |
| 57 | PRKD1 | 1.08666685 |
| 58 | JAK1 | 1.06264132 |
| 59 | BCR | 1.05409562 |
| 60 | CAMK2B | 1.04976371 |
| 61 | MAP3K6 | 1.04969978 |
| 62 | LIMK1 | 1.02135341 |
| 63 | FGFR2 | 1.01563172 |
| 64 | PRKG2 | 1.01291167 |
| 65 | MATK | 1.00334556 |
| 66 | KIT | 0.98713993 |
| 67 | PIK3CA | 0.98537263 |
| 68 | CSNK1A1L | 0.98138447 |
| 69 | PIM2 | 0.97751547 |
| 70 | PIK3CG | 0.97743877 |
| 71 | BLK | 0.96282828 |
| 72 | DDR2 | 0.96040785 |
| 73 | EPHA3 | 0.95994622 |
| 74 | WNK1 | 0.95190420 |
| 75 | IRAK4 | 0.95065480 |
| 76 | PDPK1 | 0.94999672 |
| 77 | PTK2 | 0.92435781 |
| 78 | ROCK2 | 0.92083627 |
| 79 | PTK6 | 0.89839402 |
| 80 | TLK1 | 0.88678298 |
| 81 | NEK6 | 0.88515989 |
| 82 | NEK9 | 0.84164263 |
| 83 | CSNK1G3 | 0.84029096 |
| 84 | FGFR3 | 0.82037640 |
| 85 | HIPK2 | 0.81192090 |
| 86 | OBSCN | 0.78206959 |
| 87 | MAPKAPK3 | 0.77135551 |
| 88 | PDGFRB | 0.75682915 |
| 89 | IRAK2 | 0.75669294 |
| 90 | CAMK2G | 0.75125189 |
| 91 | GRK6 | 0.74656883 |
| 92 | DMPK | 0.74175639 |
| 93 | FES | 0.73711166 |
| 94 | MYLK | 0.72955379 |
| 95 | IKBKB | 0.72539694 |
| 96 | JAK2 | 0.70291383 |
| 97 | SMG1 | 0.69907273 |
| 98 | CSK | 0.69775699 |
| 99 | TBK1 | 0.68673619 |
| 100 | HCK | 0.68319915 |
| 101 | UHMK1 | 0.66453026 |
| 102 | MOS | 0.66418209 |
| 103 | BTK | 0.64165252 |
| 104 | STK24 | 0.63498900 |
| 105 | GSK3A | 0.63374205 |
| 106 | TAOK3 | 0.63128456 |
| 107 | CAMKK2 | 0.62651918 |
| 108 | BMPR1B | 0.61940579 |
| 109 | TTN | 0.61621764 |
| 110 | LATS2 | 0.61336557 |
| 111 | SGK223 | 0.58842613 |
| 112 | SGK494 | 0.58842613 |
| 113 | NUAK1 | 0.58748653 |
| 114 | ERBB4 | 0.58646929 |
| 115 | PDK1 | 0.58588262 |
| 116 | RPS6KA2 | 0.57390089 |
| 117 | RET | 0.57137070 |
| 118 | PHKG2 | 0.56840097 |
| 119 | PHKG1 | 0.56840097 |
| 120 | MKNK2 | 0.55620859 |
| 121 | SYK | 0.55470928 |
| 122 | IKBKE | 0.54074841 |
| 123 | GRK7 | 0.53388486 |
| 124 | PRKCE | 0.51977965 |
| 125 | MAP3K14 | 0.51872261 |
| 126 | NTRK1 | 0.51789889 |
| 127 | PAK2 | 0.51699986 |
| 128 | MAPK12 | 0.51508338 |
| 129 | MARK2 | 0.51138134 |
| 130 | ABL1 | 0.50886174 |
| 131 | TEC | 0.50616452 |
| 132 | ABL2 | 0.50587921 |
| 133 | ERN1 | 0.49979467 |
| 134 | RPS6KA5 | 0.49721566 |
| 135 | BMPR2 | 0.49273098 |
| 136 | STK38 | 0.48907867 |
| 137 | CSF1R | 0.48551181 |
| 138 | MAP3K5 | 0.48455663 |
| 139 | MAPK11 | 0.48349160 |
| 140 | PRPF4B | 0.47562940 |
| 141 | DYRK2 | 0.47445363 |
| 142 | PRKAA2 | 0.47282662 |
| 143 | EIF2AK2 | 0.46965561 |
| 144 | STK10 | 0.46960069 |
| 145 | PTK2B | 0.46143479 |
| 146 | SGK3 | 0.45823314 |
| 147 | LCK | 0.44542784 |
| 148 | LYN | 0.43631182 |
| 149 | FER | 0.43619728 |
| 150 | MAP2K6 | 0.43463753 |
| 151 | EPHB2 | 0.41684866 |
| 152 | LRRK2 | 0.41535803 |
| 153 | PKN2 | 0.41352394 |
| 154 | MAPK7 | 0.41269129 |
| 155 | BMX | 0.40840437 |
| 156 | KDR | 0.40750289 |
| 157 | MAPKAPK2 | 0.40457619 |
| 158 | GRK1 | 0.40166136 |
| 159 | LATS1 | 0.39822744 |
| 160 | CAMK2A | 0.39754443 |
| 161 | ROCK1 | 0.39433788 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.11617660 |
| 2 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.81925694 |
| 3 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.65936796 |
| 4 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.94610350 |
| 5 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.76722419 |
| 6 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.58014622 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.30873097 |
| 8 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.29252498 |
| 9 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.18481079 |
| 10 | Histidine metabolism_Homo sapiens_hsa00340 | 2.02410610 |
| 11 | Other glycan degradation_Homo sapiens_hsa00511 | 1.98325603 |
| 12 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.97367134 |
| 13 | Malaria_Homo sapiens_hsa05144 | 1.85620933 |
| 14 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.83368153 |
| 15 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.82176216 |
| 16 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.81902306 |
| 17 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.75248294 |
| 18 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.67001785 |
| 19 | Lysosome_Homo sapiens_hsa04142 | 1.59949304 |
| 20 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.56936368 |
| 21 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.55004589 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.39274048 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.37923074 |
| 24 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.36599593 |
| 25 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.34355093 |
| 26 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.34292636 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.34241526 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.29789588 |
| 29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.26545666 |
| 30 | Mineral absorption_Homo sapiens_hsa04978 | 1.24938694 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21785768 |
| 32 | Galactose metabolism_Homo sapiens_hsa00052 | 1.20982047 |
| 33 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.14515970 |
| 34 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.14067523 |
| 35 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.11692352 |
| 36 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.08499441 |
| 37 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.07925149 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06330027 |
| 39 | Prion diseases_Homo sapiens_hsa05020 | 1.06163352 |
| 40 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.05694138 |
| 41 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.04747688 |
| 42 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.03384408 |
| 43 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.02261591 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.02042070 |
| 45 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.01754128 |
| 46 | Bladder cancer_Homo sapiens_hsa05219 | 1.00792782 |
| 47 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.00320582 |
| 48 | Allograft rejection_Homo sapiens_hsa05330 | 0.99909597 |
| 49 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99716077 |
| 50 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.98930570 |
| 51 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.97714058 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96474941 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 0.95996861 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.94279331 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.93255455 |
| 56 | Influenza A_Homo sapiens_hsa05164 | 0.92452908 |
| 57 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.91868755 |
| 58 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.91340721 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.91212215 |
| 60 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.90098598 |
| 61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.87913227 |
| 62 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.85394655 |
| 63 | Legionellosis_Homo sapiens_hsa05134 | 0.81816340 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.81216538 |
| 65 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.81119619 |
| 66 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.80764074 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.80294996 |
| 68 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.79990281 |
| 69 | Retinol metabolism_Homo sapiens_hsa00830 | 0.79251500 |
| 70 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78812370 |
| 71 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78491104 |
| 72 | Tight junction_Homo sapiens_hsa04530 | 0.78238812 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.78020684 |
| 74 | Viral myocarditis_Homo sapiens_hsa05416 | 0.77972295 |
| 75 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.76244625 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76164237 |
| 77 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.76147408 |
| 78 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75906395 |
| 79 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.75496324 |
| 80 | Apoptosis_Homo sapiens_hsa04210 | 0.74197152 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.73918336 |
| 82 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.73001911 |
| 83 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.72987091 |
| 84 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.72686206 |
| 85 | Insulin resistance_Homo sapiens_hsa04931 | 0.72624698 |
| 86 | Focal adhesion_Homo sapiens_hsa04510 | 0.71482469 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.71449905 |
| 88 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.71441398 |
| 89 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.71438549 |
| 90 | Peroxisome_Homo sapiens_hsa04146 | 0.71374342 |
| 91 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.71073755 |
| 92 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.69734994 |
| 93 | Amoebiasis_Homo sapiens_hsa05146 | 0.69056204 |
| 94 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.68702632 |
| 95 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.68121022 |
| 96 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.66953285 |
| 97 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.64933920 |
| 98 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.64843287 |
| 99 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64562565 |
| 100 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.64014937 |
| 101 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.63593833 |
| 102 | Bile secretion_Homo sapiens_hsa04976 | 0.63236837 |
| 103 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.63149338 |
| 104 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.60929636 |
| 105 | ABC transporters_Homo sapiens_hsa02010 | 0.60421105 |
| 106 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.59266740 |
| 107 | Measles_Homo sapiens_hsa05162 | 0.59094354 |
| 108 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.57833759 |
| 109 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57484118 |
| 110 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.56963162 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.56699210 |
| 112 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.56479363 |
| 113 | Asthma_Homo sapiens_hsa05310 | 0.56050772 |
| 114 | Axon guidance_Homo sapiens_hsa04360 | 0.55689451 |
| 115 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.55376390 |
| 116 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54837859 |
| 117 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.54636276 |
| 118 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.54541373 |
| 119 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.54340760 |
| 120 | Salmonella infection_Homo sapiens_hsa05132 | 0.54169231 |
| 121 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.53995697 |
| 122 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.53250529 |
| 123 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.52881420 |
| 124 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.52813779 |
| 125 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.52688979 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.51731969 |
| 127 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.51330403 |
| 128 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.50946505 |
| 129 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.50241050 |
| 130 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49612001 |
| 131 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.48400661 |
| 132 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48244796 |
| 133 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.47657353 |
| 134 | Hepatitis B_Homo sapiens_hsa05161 | 0.47398648 |
| 135 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47255806 |
| 136 | Hepatitis C_Homo sapiens_hsa05160 | 0.47069694 |
| 137 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46689830 |
| 138 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.46515343 |
| 139 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46203056 |
| 140 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45347357 |
| 141 | Leishmaniasis_Homo sapiens_hsa05140 | 0.42697986 |
| 142 | Endocytosis_Homo sapiens_hsa04144 | 0.42668383 |
| 143 | Sulfur relay system_Homo sapiens_hsa04122 | 0.42152548 |
| 144 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.41545066 |
| 145 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.41197224 |
| 146 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39654297 |
| 147 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.37446308 |
| 148 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.35943756 |
| 149 | Prostate cancer_Homo sapiens_hsa05215 | 0.35094037 |
| 150 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.34709802 |
| 151 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.34582811 |
| 152 | Alzheimers disease_Homo sapiens_hsa05010 | 0.34030604 |
| 153 | Shigellosis_Homo sapiens_hsa05131 | 0.33844141 |
| 154 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.33732083 |
| 155 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33635573 |

